Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible…
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and…
Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare…
Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in fiscal…
